{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T13:44:00Z","timestamp":1790516640631,"version":"4.1.0"},"reference-count":34,"publisher":"Japanese Society for Lymphoreticular Tissue Research","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Clin Exp Hematopathol","JCEH"],"published-print":{"date-parts":[[2012]]},"DOI":"10.3960\/jslrt.52.17","type":"journal-article","created":{"date-parts":[[2012,6,17]],"date-time":"2012-06-17T22:51:42Z","timestamp":1339973502000},"page":"17-22","source":"Crossref","is-referenced-by-count":37,"title":["CADM1\/TSLC1 is a Novel Cell Surface Marker for Adult T-Cell Leukemia\/Lymphoma"],"prefix":"10.3960","volume":"52","author":[{"given":"Shingo","family":"Nakahata","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiro","family":"Morishita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2349","reference":[{"key":"1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1349-7006.2005.00089.x"},{"key":"2","doi-asserted-by":"publisher","DOI":"10.1006\/geno.1999.6001"},{"key":"3","doi-asserted-by":"publisher","DOI":"10.1111\/j.1349-7006.2003.tb01499.x"},{"key":"4","unstructured":"4 Yageta M, Kuramochi M, Masuda M, Fukami T, Fukuhara H, <I>et al<\/I>.: Direct association of TSLC1 and DAL-1, two distinct tumor suppressor proteins in lung cancer. Cancer Res 62:5129-5133, 2002"},{"key":"5","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M203620200"},{"key":"6","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-02-0817"},{"key":"7","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.95.14.8153"},{"key":"8","doi-asserted-by":"publisher","DOI":"10.1038\/86934"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9 Murakami Y: Functional cloning of a tumor suppressor gene, <I>TSLC1<\/I>, in human non-small cell lung cancer. Oncogene 21:6936-6948, 2002","DOI":"10.1038\/sj.onc.1205825"},{"key":"10","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.11348"},{"key":"11","doi-asserted-by":"crossref","unstructured":"12 Sasaki H, Nishikata I, Shiraga T, Akamatsu E, Fukami T, <I>et al<\/I>.: Overexpression of a cell adhesion molecule, TSLC1, as a possible molecular marker for acute-type of adult T-cell leukemia. Blood 105:1204-1213, 2005","DOI":"10.1182\/blood-2004-03-1222"},{"key":"12","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.79.6.2031"},{"key":"13","doi-asserted-by":"publisher","DOI":"10.1186\/1742-4690-2-16"},{"key":"14","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1208968"},{"key":"15","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0215(20000201)85:3<319::AID-IJC4>3.0.CO;2-B"},{"key":"16","doi-asserted-by":"crossref","unstructured":"17 Yoshida M: Multiple viral strategies of HTLV-1 for dysregulation of cell growth control. Annu Rev Immunol 19:475-496, 2001","DOI":"10.1146\/annurev.immunol.19.1.475"},{"key":"17","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.20007"},{"key":"18","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.02511-06"},{"key":"19","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.76.18.9389-9397.2002"},{"key":"20","doi-asserted-by":"publisher","DOI":"10.1186\/1742-4690-2-64"},{"key":"21","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0507631103"},{"key":"22","doi-asserted-by":"crossref","unstructured":"23 Okamoto T, Ohno Y, Tsugane S, Watanabe S, Shimoyama M, <I>et al<\/I>.: Multi-step carcinogenesis model for adult T-cell leukemia. Jpn J Cancer Res 80:191-195, 1989","DOI":"10.1111\/j.1349-7006.1989.tb02289.x"},{"key":"23","unstructured":"24 Kamada N, Sakurai M, Miyamoto K, Sanada I, Sadamori N, <I>et al<\/I>.: Chromosome abnormalities in adult T-cell leukemia\/lymphoma : a karyotype review committee report. Cancer Res 52:1481-1493, 1992"},{"key":"24","doi-asserted-by":"crossref","unstructured":"25 Hidaka T, Nakahata S, Hatakeyama K, Hamasaki M, Yamashita K, <I>et al<\/I>.: Down-regulation of TCF8 is involved in the leukemogenesis of adult T-cell leukemia\/lymphoma. Blood 112:383-393, 2008","DOI":"10.1182\/blood-2008-01-131185"},{"key":"25","doi-asserted-by":"publisher","DOI":"10.1126\/science.278.5340.1059"},{"key":"26","unstructured":"27 Nosaka K, Maeda M, Tamiya S, Sakai T, Mitsuya H, <I>et al<\/I>.: Increasing methylation of the <I>CDKN2A<\/I> gene is associated with the progression of adult T-cell leukemia. Cancer Res 60:1043-1048, 2000"},{"key":"27","doi-asserted-by":"crossref","unstructured":"28 Timens W: Cell adhesion molecule expression and homing of hematologic malignancies. Crit Rev Oncol Hematol 19:111-129, 1995","DOI":"10.1016\/1040-8428(94)00140-O"},{"key":"28","doi-asserted-by":"crossref","unstructured":"30 Yasuda N, Lai PK, Ip SH, Kung PC, Hinuma Y, <I>et al<\/I>.: Soluble interleukin 2 receptors in sera of Japanese patients with adult T cell leukemia mark activity of disease. Blood 71:1021-1026, 1988","DOI":"10.1182\/blood.V71.4.1021.1021"},{"key":"29","doi-asserted-by":"crossref","unstructured":"31 Kamihira S, Atogami S, Sohda H, Momita S, Yamada Y, <I>et al<\/I>.: Significance of soluble interleukin-2 receptor levels for evaluation of the progression of adult T-cell leukemia. Cancer 73:2753-2758, 1994","DOI":"10.1002\/1097-0142(19940601)73:11<2753::AID-CNCR2820731117>3.0.CO;2-X"},{"key":"30","doi-asserted-by":"crossref","unstructured":"33 Nakahata S, Saito Y, Marutsuka K, Hidaka T, Maeda K, <I>et al<\/I>.: Clinical significance of CADM1\/TSLC1\/IgSF4 expression in adult T-cell leukemia\/lymphoma. Leukemia [Published online : January 6, 2012, DOI: 10.1038\/leu.2011.379]","DOI":"10.1038\/leu.2011.379"},{"key":"31","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2004.04999.x"},{"key":"32","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1207761"},{"key":"33","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V99.5.1505"},{"key":"34","doi-asserted-by":"crossref","unstructured":"38 Baatar D, Olkhanud P, Sumitomo K, Taub D, Gress R, <I>et al<\/I>.: Human peripheral blood T regulatory cells (Tregs), functionally primed CCR4<SUP>+<\/SUP> Tregs and unprimed CCR4<SUP>-<\/SUP> Tregs, regulate effector T cells using FasL. J Immunol 178:4891-4900, 2007","DOI":"10.4049\/jimmunol.178.8.4891"}],"container-title":["Journal of Clinical and Experimental Hematopathology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2021,5,20]],"date-time":"2021-05-20T19:46:09Z","timestamp":1621539969000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jslrt\/52\/1\/52_17\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.3960\/jslrt.52.17","relation":{},"ISSN":["1346-4280","1880-9952"],"issn-type":[{"value":"1346-4280","type":"print"},{"value":"1880-9952","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012]]}}}